Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Fluxion Biosciences in June, 2020 for $308,559.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL150946-01 | Phase I | 308,559 | June 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Fluxion Biosciences in September, 2018 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA224894-01A1 | Phase I | 300,000 | September 10, 2018 | |||||||
A SBIR Phase I contract was awarded to Fluxion Biosciences in September, 2019 for $284,132.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HD100217-01 | Phase I | 284,132 | September 16, 2019 | |||||||
A SBIR Phase II contract was awarded to Fluxion Biosciences for $1,819,560.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM083384-02 | Phase II | 1,819,560 | ||||||||
A SBIR Phase I contract was awarded to Fluxion Biosciences for $101,850.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM075509-01 | Phase I | 101,850 | ||||||||
A SBIR Phase I contract was awarded to Fluxion Biosciences for $117,700.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM083384-01A1 | Phase I | 117,700 | ||||||||
A SBIR Phase II contract was awarded to Fluxion Biosciences for $635,981.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM075509-02 | Phase II | 635,981 | ||||||||
A SBIR Phase I contract was awarded to Fluxion Biosciences for $203,579.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA141741-01 | Phase I | 203,579 |